Long covid: cross sectional study

Authors

  • Manuel Antonio Prieto Central de Emergencias de Adultos. Hospital Italiano de San Justo Agustín Rocca, Buenos Aires, Argentina.
  • Omar Prieto Docente de la Universidad de Buenos Aires
  • Horacio Matias Castro Sección de Neumonologia, Hospital Italiano de Buenos Aires, Argentina. https://orcid.org/0000-0002-6617-2695

DOI:

https://doi.org/10.31053/1853.0605.v78.n1.32048

Keywords:

COVID-19, SARS-CoV-2, symptoms, fatigue, follow up studies

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) is a public health problem worldwide. After 3 weeks of the onset of the disease, between 10-87% of patients persist with symptoms. The objective of the study was to evaluate the persistence of symptoms in patients with COVID-19, the associated factors, and to explore the patients' perception of the disease.

Materials and methods: We conducted a cross-sectional study that included 85 patients with a confirmed diagnosis of COVID-19, who attended on an outpatient basis after the acute phase (> 3 weeks) of the disease.

Results: The median time from diagnosis to outpatient consultation was 53 days (interquartile range 31-65). Most (86%) had mild disease, 45% were women and the mean age was 43 years (standard deviation of 13). After the acute phase of the disease 52% (95% CI 41-63%) of the patients persisted with symptoms. The most frequently persistent symptoms were fatigue (49%) and cough (33%). Nineteen percent had insomnia and sixteen percent had anxiety. Female sex, obesity, age between 35-55 years, and initial hospitalization were associated with the persistence of symptoms. Twenty percent of the patients stopped following the prevention recommendations because they believed they were immunized.

Conclusion: More than half of the patients persisted with symptoms 3 weeks after the COVID-19 diagnosis, so medical follow-up is important. Female sex, obesity, age 35-55 years, and initial hospitalization were associated factors. The symptoms usually resolved over time.

Downloads

Download data is not yet available.

Author Biographies

Manuel Antonio Prieto, Central de Emergencias de Adultos. Hospital Italiano de San Justo Agustín Rocca, Buenos Aires, Argentina.

Médico especialista en Medicina interna. 

Omar Prieto, Docente de la Universidad de Buenos Aires

Especialista en Cardiología. 

Horacio Matias Castro, Sección de Neumonologia, Hospital Italiano de Buenos Aires, Argentina.

Especialista en Medicina Interna y Neumonología. 

References

Referencias:

Home - Johns Hopkins Coronavirus Resource Center. En https://coronavirus.jhu.edu/; consultado el 31 de octubre de 2020.

Grant MC, Geoghegan L, Arbyn M, et al. The Prevalence of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries. PLoS One 2020; 23:1-19.

Carfì A., Bernabei R, Landi F, et al. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020; 324: 603-605.

COVID Symptom Study. How long does COVID-19 last? Kings College London, 2020.

En https://covid19.joinzoe.com/post/covid-long-term?fbclid=IwAR1RxIcmmdL-EFjh_aI; consultado octubre de 2020.

Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. medRxiv 2020.08.12.20173526.

Greenhalgh T, Knight M, A’Court C, et al. Management of post-acute covid-19 in primary care. BMJ 2020; 370:m3026.

Carvalho-Schneider C, Laurent E, Lemaignen, et al. Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset. Clin. Microbiol. Infect 2020.

Zhao YM, Shang YM, Song WB, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine 2020.

Huang Y, Lu Y, Huang YM, et al. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism 2020; 113.

Gousseff M, Penot P, Gallay L, et al. Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? J. Infect 2020; 81: 816–846.

To KK, Hung IF, Ip JD, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin. Infect. Dis. 2020.

Lam MH, Wing YK, Yu MW, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch. Intern. Med 2009; 169:2142–2147.

Published

2021-03-17

How to Cite

1.
Prieto MA, Prieto O, Castro HM. Long covid: cross sectional study. Rev Fac Cien Med Univ Nac Cordoba [Internet]. 2021 Mar. 17 [cited 2024 Jul. 3];78(1):33-6. Available from: https://revistas.unc.edu.ar/index.php/med/article/view/32048

Issue

Section

Original Papers